These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15065091

  • 1. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
    Jiang F, Wang Z.
    Prostate; 2004 Jun 01; 59(4):426-35. PubMed ID: 15065091
    [Abstract] [Full Text] [Related]

  • 2. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
    Kikugawa T, Kinugasa Y, Shiraishi K, Nanba D, Nakashiro K, Tanji N, Yokoyama M, Higashiyama S.
    Prostate; 2006 Jul 01; 66(10):1092-9. PubMed ID: 16637071
    [Abstract] [Full Text] [Related]

  • 3. Gadd45gamma is androgen-responsive and growth-inhibitory in prostate cancer cells.
    Jiang F, Wang Z.
    Mol Cell Endocrinol; 2004 Jan 15; 213(2):121-9. PubMed ID: 15062559
    [Abstract] [Full Text] [Related]

  • 4. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C.
    Cancer Res; 2002 Feb 01; 62(3):721-33. PubMed ID: 11830526
    [Abstract] [Full Text] [Related]

  • 5. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S, Gleave ME, Nelson CC.
    Prostate; 2004 May 15; 59(3):337-49. PubMed ID: 15042610
    [Abstract] [Full Text] [Related]

  • 6. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 15; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 7. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE, Shu WP, Kirschenbaum A, Levine AC, Miniati DN, Liu BC.
    Prostate; 1996 Dec 15; 29(6):362-70. PubMed ID: 8977633
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
    Collett GP, Betts AM, Johnson MI, Pulimood AB, Cook S, Neal DE, Robson CN.
    Clin Cancer Res; 2000 Aug 15; 6(8):3241-8. PubMed ID: 10955810
    [Abstract] [Full Text] [Related]

  • 9. The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide.
    Hobisch A, Fritzer A, Comuzzi B, Fiechtl M, Malinowska K, Steiner H, Bartsch G, Culig Z.
    Prostate; 2006 Mar 01; 66(4):413-20. PubMed ID: 16302272
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
    Hobisch A, Fiechtl M, Sandahl-Sorensen B, Godoy-Tundidor S, Artner-Dworzak E, Ramoner R, Bartsch G, Culig Z.
    Prostate; 2004 Jun 01; 59(4):401-8. PubMed ID: 15065088
    [Abstract] [Full Text] [Related]

  • 11. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
    Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ, Brinkmann AO.
    Cancer Res; 1997 Sep 15; 57(18):4075-81. PubMed ID: 9307296
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.
    Clin Cancer Res; 2001 Sep 15; 7(9):2941-8. PubMed ID: 11555613
    [Abstract] [Full Text] [Related]

  • 13. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 14. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 01; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 15. Regulation of S100P expression by androgen.
    Averboukh L, Liang P, Kantoff PW, Pardee AB.
    Prostate; 1996 Dec 01; 29(6):350-5. PubMed ID: 8977631
    [Abstract] [Full Text] [Related]

  • 16. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA, Naz RK.
    Cancer Res; 2003 Jan 15; 63(2):329-36. PubMed ID: 12543784
    [Abstract] [Full Text] [Related]

  • 17. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
    Lee MY, Moon JS, Park SW, Koh YK, Ahn YH, Kim KS.
    Biochem J; 2009 Jan 01; 417(1):313-22. PubMed ID: 18774944
    [Abstract] [Full Text] [Related]

  • 18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 19. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 20. Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.
    Bruckheimer EM, Spurgers K, Weigel NL, Logothetis C, McDonnell TJ.
    J Urol; 2003 Apr 01; 169(4):1553-7. PubMed ID: 12629413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.